CARE

Search documents
Amazon, A Small Pharmacy Player, Seeks To Dent CVS And Walgreens Medicare Share
Forbes· 2025-06-03 13:01
Core Insights - Amazon Pharmacy is launching new features aimed at attracting seniors covered by Medicare's drug benefit, a market currently dominated by CVS Health and Walgreens [2][4] - The new "caregiver support feature" allows customers to have someone else manage their medications, enhancing convenience for those caring for elderly family members [3][8] - Customers with Medicare Part D can access PillPack, which simplifies medication management through pre-sorted and labeled packets delivered to their homes [4][6] Market Context - The U.S. prescription market is largely controlled by CVS and Walgreens, which together hold a 40% market share, while Amazon's share is less than 1% [6] - CVS filled 435 million prescriptions in Q1, a 4.3% increase year-over-year, while Walgreens filled over 309 million prescriptions, up 3.4% [5] - Combined, CVS and Walgreens generated over $370 billion in prescription revenues last year [5] Demographic Trends - The Medicare prescription market is expanding, with over 11,000 Americans turning 65 every day, indicating a growing customer base for Amazon Pharmacy [6] - More than 50 million Americans are currently caring for an aging family member, presenting a significant opportunity for Amazon to cater to this demographic [7]
PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
Prnewswire· 2025-06-03 12:31
Core Insights - Veris Health Inc. has established a strategic partnership with The Ohio State University Comprehensive Cancer Center (OSUCCC – James) following a successful pilot program of the Veris Cancer Care Platform™ [1][4] - The partnership aims to enhance personalized cancer care through remote patient monitoring and the development of the Veris Cancer Care Platform [2][3] Group 1: Partnership Details - The agreement includes a long-term, multi-project collaboration to further develop and commercialize the Veris Cancer Care Platform and its implantable physiologic monitor [2][3] - Key components of the partnership involve expanding commercial utilization across cancer care service lines, full electronic health record (EHR) integration, and launching a large clinical registry and clinical trial [3][4] Group 2: Platform Features - The Veris Cancer Care Platform offers remote physiological data collection, symptom reporting, telehealth capabilities, and EHR integration, aiming to improve personalized cancer care [4][5] - Patients enrolled in the platform receive a VerisBox™ with connected health care devices that transmit data to a cloud-based clinician portal, along with a patient smartphone app for symptom reporting and health tracking [5] Group 3: Company Background - PAVmed Inc. is a diversified commercial-stage medical technology company operating in medical devices, diagnostics, and digital health sectors, with Veris Health as its majority-owned subsidiary [7] - Veris Health focuses on enhancing personalized cancer care through innovative technologies, including the development of an implantable physiological monitor [7]
Nanox to Participate in Sidoti Small Cap Conference
Globenewswire· 2025-06-03 12:30
Company Overview - Nanox Imaging Ltd (NASDAQ: NNOX) is an innovative medical imaging technology company focused on transitioning to preventive health care through affordable medical imaging technologies based on advanced AI and proprietary digital X-ray sources [3][4]. Upcoming Event - Nanox will participate in the Sidoti Small Cap Conference, scheduled for June 11-12, 2025, with management presenting on June 11 at 1:45 PM ET [1]. Technology and Solutions - The company aims to expand the reach of its technology beyond hospital settings, providing a seamless end-to-end solution from scan to diagnosis, enhancing efficiency in routine medical imaging processes [4]. - Nanox's ecosystem includes several components: - Nanox.ARC, a cost-effective multi-source digital tomosynthesis system - Nanox.AI Ltd., which offers AI-based algorithms to augment routine CT imaging readings - Nanox.CLOUD, a cloud-based platform for data management and imaging analysis - Nanox.MARKETPLACE, a decentralized marketplace for remote access to radiology and cardiology experts [4]. Vision and Goals - The company's vision is to improve early detection and treatment of diseases, ultimately enhancing health outcomes worldwide [4].
QHSLab, Inc. Publishes Peer-Reviewed Studies Validating Digital Tools for Enhancing Patient Outcomes and Healthcare Efficiency
Globenewswire· 2025-06-03 12:30
Recent publications highlight the efficacy of QHSLab's digital assessments in primary care, offering benefits for providers, patients, and practice revenue. WEST PALM BEACH, FL, June 03, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), a digital health company advancing personalized medicine through innovative population health screening and point of care diagnostic tools in primary care, announces the publication of two significant peer-reviewed studies in the last week of May 2025. The ...
Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 2025
Globenewswire· 2025-06-03 10:57
Group 1 - The event is scheduled for Tuesday, 2 September 2025, at Clarion Hotel, Copenhagen, from 10.30 to 17.00 CEST, and will include both in-person and virtual participation options [1][2]. - The purpose of the event is to introduce institutional investors and financial analysts to Coloplast's new 5-year strategy and to facilitate meetings with the management team [2][3]. - The agenda includes a plenary session covering the new Group strategy, financial updates, and strategies for Chronic Care and Voice and Respiratory Care, followed by Q&A breakout sessions [4][5]. Group 2 - The plenary session will feature key executives, including Lars Rasmussen (Interim President and CEO) and Anders Lonning-Skovgaard (Executive Vice President, CFO) [4]. - Breakout sessions will focus on specific areas such as Chronic Care, Advanced Wound Care, Interventional Urology, and Global Operations, led by senior executives in those fields [5]. - In-person participation requires registration by 15 August 2025, while virtual participation will be available for the plenary session [6][7].
按需健康:更智能的福利,更强大的劳动力
威达信· 2025-06-03 06:40
Health on Demand Smarter Benefits, Stronger Workforce Health on Demand 2025. Smarter Benefits, Stronger Workforce. Introduction The world has experienced profound change in recent years, and as we move through 2025, the pace of change is only accelerating. Alongside geopolitical conflicts, trade wars, record-breaking temperatures, extreme weather events and the spread of misinformation, employees are grappling with the changing world of work, technological disruptions and the rapid adoption of AI. In the fa ...
UnitedHealth investors approve new CEO's $60M pay package despite turmoil following top executive's assassination
New York Post· 2025-06-02 20:30
Core Viewpoint - UnitedHealth is facing significant challenges, including financial losses, criminal fraud allegations, and the murder of a top executive, while simultaneously approving a substantial pay package for its new CEO, Stephen Hemsley, which includes $60 million in stock [1][3][12]. Financial Performance - UnitedHealth reported its first earnings miss since 2008, leading to a market capitalization decline of over $250 billion since its peak in November [1][3]. - The company's stock price fell approximately 40% this year, with a notable drop of 22% on April 17, resulting in a loss of about $119 billion in market value [10][11]. Executive Changes - Stephen Hemsley returned as CEO last month after Andrew Witty stepped down, having served for four years [1][3][5]. - Hemsley's compensation package is reported to be aligned with median CEO pay in comparable companies, including a $1 million annual salary [2][3]. Legal and Ethical Issues - UnitedHealth is under investigation by the Department of Justice for potential Medicare fraud, and shareholders have filed a lawsuit alleging the company concealed the impact of the murder of Brian Thompson on its business [7][8][10]. - The company is conducting a review of its risk assessment and management practices, which will be overseen by independent experts [12]. Management and Strategy - Hemsley has expressed a commitment to restoring investor trust and improving company performance [12]. - The previous CEO, Andrew Witty, implemented changes that initially boosted profits but also increased the company's exposure to risks, particularly following changes in Medicare payment rules [17][18].
The Ensign Group Acquires Two Skilled Nursing Facilities in Idaho
Globenewswire· 2025-06-02 20:05
SAN JUAN CAPISTRANO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the operations of Ironwood Rehabilitation and Care Center, an 80-bed skilled nursing facility located in Coeur d’Alene, Idaho and Lakeside Reha ...
The Ensign Group Adds Skilled Nursing Facility in California
Globenewswire· 2025-06-02 20:05
SAN JUAN CAPISTRANO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the EnsignTM group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the operations of Toluca Lake Transitional Care, a 52-bed skilled nursing facility located in North Hollywood, California. The real estate wil ...
New Synchrony Study Finds Nearly 8 out of 10 Pet Owners Underestimate the Cost of Care, Reaching Up to $61,000 During a Pet's Lifetime
Prnewswire· 2025-06-02 13:30
Core Insights - The 2025 Pet Lifetime of Care Study by Synchrony reveals a significant increase in lifetime pet care costs, with costs for dogs rising over 10% and nearly 20% for cats compared to 2022 findings [1][2][5] - The study indicates that nearly 80% of pet owners underestimate the lifetime care costs for their pets, highlighting a gap between perceived and actual expenses [1][2][3] Pet Care Cost Trends - The average lifetime cost of dog ownership is estimated to range from $22,125 to $60,602, an increase from the previous range of $20,000 to $55,000 [5][6] - For cats, the estimated lifetime care costs range from $20,073 to $47,106, reflecting a 19.4% increase from previous estimates [5][7] - Small companion animals, such as hamsters and guinea pigs, have an estimated lifetime care cost of $7,600 to $14,938 over a 6-year lifespan, while owners expect to spend less than $3,000 [4][5] Financial Preparedness and Solutions - A growing number of pet owners are facing unexpected expenses, with 74% reporting costs exceeding $250, while only 31% feel comfortable managing major pet expenses [2][3] - Financial worry related to pet care has increased from one in three pet owners in 2022 to nearly one in two in 2025, indicating a rising economic impact [3] - 58% of pet owners have utilized credit cards for pet care, and only 20% have dedicated savings or insurance for emergencies [3][6] Technological Investments in Pet Care - Dog owners are increasingly investing in health insurance and wellness plans, with annual costs rising from $198 to $313 for insurance and from $422 to $701 for wellness plans [5][6] - Cat owners are also embracing technology, with annual costs for tech-related products nearly doubling, reflecting a shift towards preventive care and enhanced wellbeing [7][8] Study Methodology - The 2025 Lifetime of Care study surveyed 4,861 pet owners between January 31 and February 22, 2025, focusing on spending patterns and challenges associated with pet care costs [10]